These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

114 related items for PubMed ID: 21838798

  • 1. Stable and high-level production of recombinant Factor IX in human hepatic cell line.
    de Castilho Fernandes A, Fontes A, Gonsales N, Swiech K, Picanco-Castro V, Faca S, Covas D.
    Biotechnol Appl Biochem; 2011; 58(4):243-9. PubMed ID: 21838798
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Expression of human factor IX cDNA in mice by implants of genetically modified skin fibroblasts from a hemophilia B patient.
    Zhou JM, Dai YF, Qiu XF, Hou GY, Akira Y, Xue JL.
    Sci China B; 1993 Sep; 36(9):1082-92. PubMed ID: 8274202
    [Abstract] [Full Text] [Related]

  • 6. Evaluation of recombinant human factor IX: pharmacokinetic studies in the rat and the dog.
    Keith JC, Ferranti TJ, Misra B, Frederick T, Rup B, McCarthy K, Faulkner R, Bush L, Schaub RG.
    Thromb Haemost; 1995 Jan; 73(1):101-5. PubMed ID: 7740479
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Galectin 3-binding protein is a potential contaminant of recombinantly produced factor IX.
    Blostein M, Cuerquis J, Galipeau J.
    Haemophilia; 2007 Nov; 13(6):701-6. PubMed ID: 17973845
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Expression of functional recombinant human factor IX in milk of mice.
    Lisauskas SF, Cunha NB, Vianna GR, Mendes EA, Ramos GL, Maranhão AQ, Brígido MM, Almeida JO, Baptista HA, Motta FL, Pesquero JB, Aragão FJ, Rech EL.
    Biotechnol Lett; 2008 Dec; 30(12):2063-9. PubMed ID: 18688573
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Stage I clinical trial of gene therapy for hemophilia B.
    Lu DR, Zhou JM, Zheng B, Qiu XF, Xue JL, Wang JM, Meng PL, Han FL, Ming BH, Wang XP.
    Sci China B; 1993 Nov; 36(11):1342-51. PubMed ID: 8142023
    [Abstract] [Full Text] [Related]

  • 17. The manufacturing process for recombinant factor IX.
    Harrison S, Adamson S, Bonam D, Brodeur S, Charlebois T, Clancy B, Costigan R, Drapeau D, Hamilton M, Hanley K, Kelley B, Knight A, Leonard M, McCarthy M, Oakes P, Sterl K, Switzer M, Walsh R, Foster W.
    Semin Hematol; 1998 Apr; 35(2 Suppl 2):4-10. PubMed ID: 9565160
    [Abstract] [Full Text] [Related]

  • 18. Reduced bleeding events with subcutaneous administration of recombinant human factor IX in immune-tolerant hemophilia B dogs.
    Russell KE, Olsen EH, Raymer RA, Merricks EP, Bellinger DA, Read MS, Rup BJ, Keith JC, McCarthy KP, Schaub RG, Nichols TC.
    Blood; 2003 Dec 15; 102(13):4393-8. PubMed ID: 12933577
    [Abstract] [Full Text] [Related]

  • 19. Encapsulated human primary myoblasts deliver functional hFIX in hemophilic mice.
    Wen J, Xu N, Li A, Bourgeois J, Ofosu FA, Hortelano G.
    J Gene Med; 2007 Nov 15; 9(11):1002-10. PubMed ID: 17868187
    [Abstract] [Full Text] [Related]

  • 20. Persistent and therapeutic concentrations of human factor IX in mice after hepatic gene transfer of recombinant AAV vectors.
    Snyder RO, Miao CH, Patijn GA, Spratt SK, Danos O, Nagy D, Gown AM, Winther B, Meuse L, Cohen LK, Thompson AR, Kay MA.
    Nat Genet; 1997 Jul 15; 16(3):270-6. PubMed ID: 9207793
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.